Entera Bio Ownership | Who Owns Entera Bio?
Entera Bio Ownership Summary
Entera Bio is owned by 14.14% institutional investors, 19.02% insiders, and 66.84% retail investors. Knoll capital management is the largest institutional shareholder, holding 10.57% of ENTX shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.05% of its assets in Entera Bio shares.
ENTX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Entera Bio | 14.14% | 19.02% | 66.84% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Knoll capital management | 3.88M | 10.57% | $7.14M |
Schonfeld strategic advisors | 671.76K | 1.83% | $1.24M |
Parkman healthcare partners | 401.52K | 1.09% | $738.79K |
Ubs group | 167.62K | 0.46% | $308.43K |
Renaissance | 57.60K | 0.16% | $105.98K |
Susquehanna group, llp | 28.86K | 0.08% | $53.09K |
Geode capital management | 17.60K | 0.05% | $32.38K |
Advisor group | 16.78K | 0.05% | $36.74K |
Pnc financial services group | 13.00K | 0.04% | $23.92K |
Cibc world market | 12.50K | 0.03% | $23.00K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Knoll capital management | 3.88M | 4.81% | $7.14M |
Parkman healthcare partners | 401.52K | 0.10% | $738.79K |
Schonfeld strategic advisors | 671.76K | 0.01% | $1.24M |
Renaissance | 57.60K | 0.00% | $105.98K |
Advisor group | 16.78K | 0.00% | $36.74K |
Cibc world market | 12.50K | 0.00% | $23.00K |
Newedge advisors | 9.00K | 0.00% | $16.56K |
Ubs group | 167.62K | 0.00% | $308.43K |
Geode capital management | 17.60K | - | $32.38K |
Virtu financial | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Schonfeld strategic advisors | 671.76K | 0.01% | 671.76K |
Parkman healthcare partners | 401.52K | 0.10% | 401.52K |
Ubs group | 167.62K | 0.00% | 17.75K |
Advisor group | 16.78K | 0.00% | 15.28K |
Cibc world market | 12.50K | 0.00% | 12.50K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Susquehanna group, llp | 28.86K | - | -22.77K |
Virtu financial | - | - | -22.04K |
Millennium management | - | - | -19.51K |
Renaissance | 57.60K | 0.00% | -17.30K |
Citadel advisors | - | - | -3.90K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Schonfeld strategic advisors | 671.76K | 0.01% | 671.76K | $1.24M |
Parkman healthcare partners | 401.52K | 0.10% | 401.52K | $738.79K |
Cibc world market | 12.50K | 0.00% | 12.50K | $23.00K |
Newedge advisors | 9.00K | 0.00% | 9.00K | $16.56K |
Bank of america corp /de/ | 3.00K | - | 3.00K | $5.52K |
Sold Out
Holder | Change |
---|---|
Jpmorgan chase | -2.00 |
Royal bank of canada | -3.00K |
Citadel advisors | -3.90K |
Millennium management | -19.51K |
Virtu financial | -22.04K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 19 | 35.71% | 5,323,228 | 0.57% | 14 | 6.81% | 6 | -14.29% | 3 | 50.00% |
Jun 30, 2024 | 14 | -6.67% | 5,292,989 | 24.27% | 14 | 7.01% | 7 | -22.22% | 2 | 100.00% |
Mar 31, 2024 | 15 | 50.00% | 4,259,308 | 4.84% | 14 | 7.21% | 9 | 200.00% | 1 | -50.00% |
Dec 31, 2023 | 10 | -23.08% | 4,062,589 | 57.53% | 14 | 17.60% | 3 | -50.00% | 2 | - |
Sep 30, 2023 | 13 | 18.18% | 2,579,003 | 0.38% | 8 | 11.26% | 6 | 20.00% | 2 | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Nasdaq Composite Index | 17.60K | 0.05% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 12, 2024 | Taitel Haya | - | Buy | $9.40K |
Jan 10, 2024 | Taitel Haya | - | Buy | $5.86K |
Dec 22, 2023 | LIEBERMAN GERALD M | - | Buy | $17.01K |
Dec 22, 2023 | LIEBERMAN GERALD M | - | Buy | $23.95K |
Dec 22, 2023 | Toledano Miranda Jayne | Chief Executive Officer | Buy | $17.01K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | 2 | - |
2023 Q4 | 4 | - |
ENTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools